InMode to Present at the 23rd Annual Needham Growth Conference
InMode Ltd. (Nasdaq: INMD) announced that CEO Moshe Mizrahy and CFO Yair Malca will present at the 23rd Annual Needham Growth Conference on January 14, 2021, at 8:30 am EST.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
InMode Ltd. (Nasdaq: INMD) announced that CEO Moshe Mizrahy and CFO Yair Malca will present at the 23rd Annual Needham Growth Conference on January 14, 2021, at 8:30 am EST. The presentation will be available via live webcast to the public at their investor relations website, with an archive accessible for 90 days post-event. InMode specializes in innovative medical technologies utilizing radio-frequency technology, focusing on enhancing surgical and treatment processes across various medical fields.
Details
News Market Reaction – INMD
The recorded move for INMD in the trading session of this news was +3.43%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YOKNEAM, Israel, Jan. 5, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Mr. Moshe Mizrahy, Chairman and Chief Executive Officer, and Mr. Yair Malca, Chief Financial Officer will present virtually at the 23rd Annual Needham Growth Conference on Thursday, January 14, 2021 at 8:30 am EST.
To schedule a meeting please contact your Needham salesperson or Miri Segal at ir@inmodemd.com.
A live webcast of the presentations will be available to the public at: https://inmodemd.com/investors/. The webcast will be archived for 90 days following the live presentation.
About InMode
InMode (Nasdaq: INMD) is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.
For more information about InMode, please visit www.inmodemd.com.
Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
+1-917-607-8654
View original content to download multimedia:http://www.prnewswire.com/news-releases/inmode-to-present-at-the-23rd-annual-needham-growth-conference-301200415.html
SOURCE InMode Ltd.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.